IsoRay, Inc. Reports Fiscal Year 2012 Results Non Prostate Revenues Up 75% To 14% of Total Revenues

IsoRay, Inc. Reports Fiscal Year 2012 Results Non Prostate Revenues Up 75% To 14% of Total Revenues

[at noodls] – FOR IMMEDIATE RELEASE ISORAY, INC. REPORTS FISCAL YEAR 2012 RESULTS Non Prostate Revenues Up 75% To 14% of Total Revenues RICHLAND, Washington (September 28, 2012) – IsoRay Inc. (AMEX: ISR), a medical … more

View todays social media effects on ISR

View the latest stocks trending across Twitter. Click to view dashboard

Share this post